Evicenter
P&T meetings

Cytisinicline

Smoking cessation

Last updated
86 sources

Clinical evidence

Retrospective comparative-effectiveness cohort

11 evidence topics · 1 source

Objective
Location and study date
Study design
Eligibility criteria
Adult eligibility
CharacteristicQuoted value
Minimum age, years“18”
Treatment
Medication groups
Study outcomes
Rationale for using self-reported smoking abstinence as a study endpoint
Statistical analysis description
Number of participants (Planned and analyzed)
Analyzed participants
CharacteristicQuoted value
Total cohort“113”
Description of analysis sets
Results
Participant disposition

No evidence found.

Baseline characteristics

No evidence found.

Efficacy results
Overall cessation
CharacteristicQuoted value
Participants classified as quitters“67”
Participants classified as non-quitters“46”
Health-related quality of life and patient-reported outcomes

No evidence found.

Safety results

No evidence found.

Study limitations
Summary

Treatment selection reflected routine practice rather than randomization, and multivariable modeling was not performed. The association between adherence and cessation does not establish a causal medication effect or an adjusted comparative treatment effect.